Featured Research

from universities, journals, and other organizations

UW-Madison Team Develops Technique To Create Flu Viruses

Date:
August 4, 1999
Source:
University Of Wisconsin-Madison
Summary:
A research team has perfected a method for creating designer influenza viruses, which can be tailor-made to solve mysteries about how flu strains mutate, spread and cause illness. The development may also lead to more efficient influenza vaccines and safer gene therapies.

Technology may lead to more efficient vaccines and genetic therapies

Related Articles


MADISON - A research team has perfected a method for creating designer influenza viruses, which can be tailor-made to solve mysteries about how flu strains mutate, spread and cause illness.

The development may also lead to more efficient influenza vaccines and safer gene therapies, says Yoshihiro Kawaoka, a University of Wisconsin-Madison virologist and author of the report in the Aug. 3 Proceedings of the National Academy of Sciences (PNAS).

"This technology should help us gain a greater biological understanding of influenza and improve our methods of disease control," says Kawaoka.

Scientists have tried for years to create influenza viruses in the laboratory, but the process is made difficult by of the complexity of the virus, Kawaoka says. The influenza genome has eight different segments of RNA, compared to only one in viruses such as rabies.

To accomplish the feat, the researchers used a basic ingredient in biotechnology called plasmids, which are independent segments of DNA capable of replicating on their own. Plasmids are commonly used in science to transport genetic material from one cell to another.

Kawaoka and his School of Veterinary Medicine research group introduced eight plasmids - one for each segment of flu RNA -- into a common line of cells used for research. They also introduced nine other plasmids into the cells that serve as building blocks for the proteins needed to make a complete influenza virus.

Although Kawaoka says they are not entirely sure why the system works so well, it is producing viruses in about one in every 1,000 cells. It's a 1,000-fold improvement over current methods, which only produce altered viruses but not entirely new ones.

This technology is exciting, Kawaoka says, because it allows scientists to precisely manipulate influenza viruses by flipping genetic switches and producing mutations, which can expose the flu's complex machinery.

"With this technology, we can introduce mutations any way we want," he says. "We can control the virulence by mutating here, there, anywhere. That could help us generate a live vaccine that is also stable."

Kawaoka says current inactivated flu vaccines are good, but can be improved. Live vaccines could be advantageous because they induce both cellular and antibody immune responses. They also produce immunity where it needs to be, such as the nasal cavity and respiratory tract.

There may be even broader applications in gene therapy in areas such as cancer treatment, he says. In fighting cancer, doctors want to introduce genes that effectively kill cancer cells but will not replicate in the body and damage healthy tissue. The influenza virus may be an ideal vector, Kawaoka says, because it does not get integrated into the human genome.

Influenza remains a major public health menace, killing an average of 20,000 people each year and infecting up to 40 million people in the U.S. alone. Influenza-related health costs top $4.6 billion per year. But basic mechanics of the virus, such as what triggers dangerous shifts in flu strains, are poorly understood.

Kawaoka says this technology will be valuable from a basic science perspective. They can use cloned viruses to study influenza viral growth, pathogenesis, and what allows some viruses to transmit across species.

For example, avian flu viruses almost never transfer to humans, but when they do they can be particularly deadly, such as the 1997 Hong Kong virus. "Now we can introduce mutations in the avian influenza virus and understand for the first time what makes these viruses grow in humans," he says.

A dozen researchers worked on the project, including post-doctoral researcher Gabrielle Neumann and graduate student Tokiko Watanabe. The research was supported by the National Institute of Allergy and Infectious Diseases Public Health Service, a division of the National Institutes of Health.

###

For questions or comments about UW-Madison's email news release system, please send an email to: UW-news@facstaff.wisc.edu

For more UW-Madison news, please visit the Office of News and Public Affairs Web site: http://www.wisc.edu/news/


Story Source:

The above story is based on materials provided by University Of Wisconsin-Madison. Note: Materials may be edited for content and length.


Cite This Page:

University Of Wisconsin-Madison. "UW-Madison Team Develops Technique To Create Flu Viruses." ScienceDaily. ScienceDaily, 4 August 1999. <www.sciencedaily.com/releases/1999/08/990804072653.htm>.
University Of Wisconsin-Madison. (1999, August 4). UW-Madison Team Develops Technique To Create Flu Viruses. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/1999/08/990804072653.htm
University Of Wisconsin-Madison. "UW-Madison Team Develops Technique To Create Flu Viruses." ScienceDaily. www.sciencedaily.com/releases/1999/08/990804072653.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins